相关实验视频
Updated: Jan 29, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.0K
早期自我治疗与多发性硬化症风险之间的关联:一个病例对照研究
Seyyed Amin Seyyed Rezaie1, Vahid Asgharzadeh1, Behroz Mahdavipoor2
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Endocrine, metabolic & immune disorders drug targets
|January 28, 2026
概括
儿童用皮质类固醇和催眠药进行自我治疗可能会增加多发性硬化症 (MS) 的风险. 相反,常见的补充剂和非处方药可能会对MS的发展产生保护作用.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 环境健康 环境健康
背景情况:
- 多发性硬化症 (MS) 是一种具有遗传和环境影响的慢性自身免疫中枢神经系统疾病.
- 儿童早期的自我治疗是一种潜在的环境因素,与MS的发展有关.
研究的目的:
- 调查15岁之前的自我治疗实践与患多发性硬化症的风险之间的联系.
- 区分各种药物类别和补充剂对MS风险的影响.
主要方法:
- 一项病例控制研究,涉及469名多发性硬化患者和260名来自阿塞拜疆社区的健康对照.
- 通过关于儿童自我治疗史的综合问卷收集的数据.
- 使用奇平方测试进行统计分析,以比较群体之间的药物使用模式.
主要成果:
- 多发性硬化症患者在15岁之前显著使用更多的皮质类固醇,止痛药和催眠药.
- 健康对照组报告了更频繁地使用铁/补充剂,抗胰岛素药物,乙氨基,抗生素和成人感冒药物.
- 两组之间在使用复合维生素,维生素D或NSAIDs方面没有发现显著差异.
结论:
- 儿童早期无监督使用皮质类固醇和催眠药可能会增加多发性硬化症的风险.
- 常见的补充剂和非处方药可能与MS有保护性关联.
- 在儿童时期强调负责任的药物使用和监管对于预防MS至关重要.
相关概念视频
Characteristics of Life
260.4K
Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
260.4K
Genome-wide Association Studies-GWAS
15.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.6K
Half-life of a Reaction
38.9K
The half-life of a reaction (t1/2) is the time required for one-half of a given amount of reactant to be consumed. In each succeeding half-life, half of the remaining concentration of the reactant is consumed. For example, during the decomposition of hydrogen peroxide, during the first half-life (from 0.00 hours to 6.00 hours), the concentration of H2O2 decreases from 1.000 M to 0.500 M. During the second half-life (from 6.00 hours to 12.00 hours), the concentration decreases from 0.500 M to...
38.9K
The Angiosperm Life Cycle
72.4K
Plants have a life cycle split between two multicellular stages: a haploid stage—with cells containing one set of chromosomes—and a diploid stage—with cells containing two sets of chromosomes. The haploid stage is the gamete-producing gametophyte, and the diploid stage is the spore-producing sporophyte.
72.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
427
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
427
Bioavailability Study Design: Single Versus Multiple Dose Studies
228
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
228

